Journal of immunotherapy (Hagerstown, Md. : 1997)
Brief Communication: Severe Immuno-Induced Rhinosinusitis With Deafness After Ipilimumab and Nivolumab Combination for Melanoma, and Review of the Literature.
Maëva Boyer, Mélodie Kerimian, Alix Ribadeau Dumas, Skander Korbi, Caroline Dutriaux, Margot Bouquerel, Marie Guicheney, Sorilla Prey
Published: 202510.1097/CJI.0000000000000592
Abstract
Immunotherapy with immune checkpoint inhibitors (ICI) is widely used to treat cancers, and reports of rare immune-related adverse events (irAEs) are increasing. Ear, nose, and throat (ENT) irAEs are often underestimated, as patients rarely report rhi…
Preview only. Read the full abstract at the source